Northern Trust
ERNA icon

Northern Trust’s Eterna Therapeutics ERNA Stock Holding History

Northern Trust’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$12K – 4663
2022
Q3 		$12K Hold
7
– – ﹤0.01% 4620
2022
Q2 		$25K Sell
7
-26
-79% -$187K ﹤0.01% 4586
2022
Q1 		$514K Sell
33
-3
-8% -$56.9K ﹤0.01% 3730
2021
Q4 		$1.12M Buy
36
+1
+3% +$54.4K ﹤0.01% 3498
2021
Q3 		$2.43M Buy
35
+4
+13% +$345K ﹤0.01% 3179
2021
Q2 		$4.15M Buy
+31
New +$4.46M ﹤0.01% 2962
2016
Q2 		– Hold
0
– -$4K – 4241
2016
Q1 		– Hold
0
– – – 4202
2015
Q4 		– Hold
0
– – – 4229
2015
Q3 		– Hold
0
– – – 4224
2015
Q2 		– Hold
0
– – – 4186
2015
Q1 		– Hold
0
– – – 4248
2014
Q4 		– Hold
0
– – – 4197
2014
Q3 		– Hold
0
– – – 4233
2014
Q2 		– Hold
0
– – – 4183
2014
Q1 		– Hold
0
– – – 4109
2013
Q4 		– Hold
0
– – – 4032
2013
Q3 		– Hold
0
– – – 4015
2013
Q2 		– Hold
0
– – – 4013

Other funds holding ERNA

NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Northern Trust's ERNA Position: Q4 2022 in Review

Northern Trust sold out of Eterna Therapeutics (ERNA) in Q4 2022, closing a stake of 7 shares — an estimated $12K sold.

Northern Trust first reported a position in ERNA in Q2 2021 and held it in 6 quarters. The position peaked at $4.15M in Q2 2021. 11 funds tracked by Wall St. Rank hold ERNA as of Q4 2022.

  • Northern Trust reported no remaining Eterna Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Northern Trust sold 7 Eterna Therapeutics shares in Q4 2022, an estimated $12K.
  • Northern Trust first reported a position in Eterna Therapeutics in Q2 2021 and held it in 6 quarters.
  • Northern Trust's Eterna Therapeutics position peaked at $4.15M in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.